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Malignant gliomas are most devastating and deadly forms of tumors. Prolonged exposure of 
gliomas with high concentration of anti-cancer drugs is pre-requisite for therapeutic efficacy. 
But there are several limitations depending upon physiochemical characterization of the 
compound and impermeable nature of blood brain barrier (BBB) often results in sub-
therapeutic drug concentration. Blood brain barrier is the major problem in drug delivery to 
the brain. In gliomas microvasculature exhibits physiological characteristics quite distinct from 
the intact cerebral structure. Second part of the review consist the use of non-invasive 
strategies to circumvent the BBB and deliver drug into the brain. Intranasal delivery route is 
the most suitable non-invasive route and it has the advantage of by passing the BBB and large 
number of compounds can reach the brain directly through various passages. Lipid-
nanoformulations like liposomes and solid lipid nanoparticles have been largely exploited for 
brain targeting can be the most suitable carrier for gliomas. This review summarizes the 
introduction of glioblastoma, barriers to brain delivery, best carrier system for intranasal 
delivery and mechanism in drug transport to the brain for targeting glioblastoma. 
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